Skip to search formSkip to main content

Kayexalate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Kayexalate (sodium polystyrene sulfonate in sorbitol) is commonly used for treatment of hyperkalemia. We describe the case of a… Expand
Is this relevant?
2009
2009
A 56-year-old woman with chronic kidney disease stage 3 due to diabetic glomerulopathy and focal segmental glomerulosclerosis… Expand
Is this relevant?
2007
2007
Sodium polystyrene sulfonate (SPS) (Kayexalate) is a cation-exchange resin used to treat hyperkaliema. Administered with sorbitol… Expand
Is this relevant?
2004
2004
Hyperkalaemia is a life-threatening electrolyte disorder that can occur in the first week of life in almost 50% of preterm… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Kayexalate (sodium polystyrene sulfonate) in sorbitol has been demonstrated to cause colonic necrosis in a subset of uremic… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Sodium polystyrene sulfonate (Kayexalate) in sorbitol given as an enema or orally to treat hyperkalemia has been reported to… Expand
Is this relevant?
1997
1997
BACKGROUND Kayexalate (sodium polystyrene sulphonate) in sorbitol is commonly used to treat hyperkalemia in patients with renal… Expand
  • figure 1
  • figure 2
  • figure 5
  • figure 3
  • figure 6
Is this relevant?
1997
1997
Kayexalate (Roxane Labs, Columbus, OH) in sorbitol is commonly administered by the oral and rectal route for the treatment of… Expand
Is this relevant?
Review
1993
Review
1993
The authors present the case of a patient who developed near total colonic necrosis shortly after renal transplantation. The… Expand
Is this relevant?
Highly Cited
1987
Highly Cited
1987
Five patients who suffered catastrophic colonic necrosis are presented. All patients were uremic and received sodium polystyrene… Expand
Is this relevant?